CAM
MRNA icon

Chesapeake Asset Management’s Moderna MRNA Stock Holding History

Chesapeake Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26
Closed -$737 – 459
2025
Q1 		$737 Buy
+26
New +$923 ﹤0.01% 395
2024
Q3 		– Sell
-50
Closed -$5.94K – 537
2024
Q2 		$5.94K Hold
50
– – 0.01% 234
2024
Q1 		$5.33K Hold
50
– – 0.01% 239
2023
Q4 		$4.97K Hold
50
– – ﹤0.01% 301
2023
Q3 		$5.16K Hold
50
– – 0.01% 309
2023
Q2 		$6.08K Sell
50
-72
-59% -$9.61K 0.01% 292
2023
Q1 		$18.7K Buy
+122
New +$20.1K 0.02% 195

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chesapeake Asset Management's MRNA Position: Q2 2025 in Review

Chesapeake Asset Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 26 shares — an estimated $737 sold.

Chesapeake Asset Management first reported a position in MRNA in Q1 2023 and held it in 7 quarters. The position peaked at $18.7K in Q1 2023. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Chesapeake Asset Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 26 Moderna shares in Q2 2025, an estimated $737.
  • Chesapeake Asset Management first reported a position in Moderna in Q1 2023 and held it in 7 quarters.
  • Chesapeake Asset Management's Moderna position peaked at $18.7K in Q1 2023.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.